These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 17699370)

  • 21. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 22. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pragmatic clinical trials.
    Macpherson H
    Complement Ther Med; 2004; 12(2-3):136-40. PubMed ID: 15561524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and analysis of prostate cancer trials.
    Sylvester R
    Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Don't throw out the observation studies with the bath-water. Assess their quality instead].
    Rosén M; Axelsson S; Lindblom J
    Lakartidningen; 2008 Nov 5-11; 105(45):3191-4. PubMed ID: 19062610
    [No Abstract]   [Full Text] [Related]  

  • 26. Independent design and conduct of clinical trials.
    Yusuf S; Bosch J
    Clin Trials; 2006; 3(6):503-7. PubMed ID: 17170033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some main problems eroding the credibility and relevance of randomized trials.
    Ioannidis JP
    Bull NYU Hosp Jt Dis; 2008; 66(2):135-9. PubMed ID: 18537784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality assessment in clinical trials: considerations for outcomes research in interventional pain medicine.
    Hartrick CT
    Pain Pract; 2008; 8(6):433-8. PubMed ID: 18783359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of the evaluation criteria used in clinical trials for Alzheimer's disease.
    Truffinet P; Bordet R; Ménard J
    Therapie; 2009; 64(3):139-8. PubMed ID: 19671425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translating research into clinical practice: critical interpretation of clinical trials in schizophrenia.
    Leucht S
    Int Clin Psychopharmacol; 2006 Mar; 21 Suppl 2():S1-10. PubMed ID: 16601507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overhauling clinical trials.
    Scott CT; Baker M
    Nat Biotechnol; 2007 Mar; 25(3):287-92. PubMed ID: 17344876
    [No Abstract]   [Full Text] [Related]  

  • 32. Current issues in non-inferiority trials.
    Fleming TR
    Stat Med; 2008 Feb; 27(3):317-32. PubMed ID: 17340597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Limitations and pitfalls of clinical studies in oncology].
    Cerny T
    Onkologie; 2008; 31 Suppl 2():67-71. PubMed ID: 18487873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The design and interpretation of pilot trials in clinical research in critical care.
    Arnold DM; Burns KE; Adhikari NK; Kho ME; Meade MO; Cook DJ;
    Crit Care Med; 2009 Jan; 37(1 Suppl):S69-74. PubMed ID: 19104228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designing clinical trials for NOTES.
    Romagnuolo J; Cotton P
    Gastrointest Endosc Clin N Am; 2008 Apr; 18(2):371-85; xi. PubMed ID: 18381177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research in general practice in New Zealand.
    Reid J
    N Z Med J; 2003 Nov; 116(1186):U679. PubMed ID: 14657962
    [No Abstract]   [Full Text] [Related]  

  • 38. Global benefit-risk assessment in designing clinical trials and some statistical considerations of the method.
    Pritchett YL; Tamura R
    Pharm Stat; 2008; 7(3):170-8. PubMed ID: 17538942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Gini coefficient as a measure for understanding accrual inequalities in multicenter clinical studies.
    Haidich AB; Ioannidis JP
    J Clin Epidemiol; 2004 Apr; 57(4):341-8. PubMed ID: 15135834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical trials. Methodological principles and ethical aspects in the evaluation of therapies].
    Montagne O; Macquin-Mavier I; Lejonc JL
    Rev Prat; 1998 Mar; 48(6):679-84. PubMed ID: 9781143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.